References
Savica R, Rocca WA, Ahlskog JE. (2010) When does Parkinson disease start? Arch Neurol Jul;67(7):798–801.
Graham MM, Westerhout CM, Kaul P, Norris CM, Armstrong PW. (2008) Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event. Am Heart J Dec; 156(6):1210–1216.
Cedarbaum JM, Crans G, Grundman M. (2010) Seeing with new eyes: finding a path to early intervention trials in Alzheimer’s disease. J Nutr Health Aging Apr; 14(4):306–309.
Petersen RC. (2010) Clinical trials for early (pre-dementia) Alzheimer’s disease: a case for mild cognitive impairment. J Nutr Health Aging Apr; 14(4):304–305.
Doody RS. (2010) Evolving early (pre-dementia) Alzheimer’s disease trials: suit the outcomes to the population and study design. J Nutr Health Aging Apr; 14(4):299–302.
Schneider LS. (2010) The potential and limits for clinical trials for early Alzheimer’s disease and some recommendations. J Nutr Health Aging Apr; 14(4):295–298.
Aisen PS. (2010) Pre-dementia Alzheimer’s trials: overview. J Nutr Health Aging Apr;14(4):294. Review.
Pedrosa H, De Sa A, Guerreiro M, Maroco J, Simoes MR, Galasko D, de Mendonca A. (2010) Functional evaluation distinguishes MCI patients from healthy elderly people—the ADCS/MCI/ADL scale. J Nutr Health Aging Oct; 14(8):703–709.
Chumlea WC, Cesari M, Evans WJ, Ferrucci L, Fielding RA, Pahor M, Studenski S, Vellas B. (2011) International working group on sarcopenia. J Nutr Health Aging 15(6):450–455.
Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WM, Vellas B. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. (2008) J Nutr Health Aging Aug–Sep;12(7):433–450.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel J-P, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M. (2010) Sarcopenia: European consensus on definition and diagnosis. Age and Ageing 39:412–423.
Gregory PC, Szanton SL, Xue QL, Tian J, Thorpe RJ, Fried LP. (2011) Education predicts incidence of preclinical mobility disability in initially high-functioning older women. The Women’s Health and Aging Study II. J Gerontol A Biol Sci Med Sci May; 66(5):577–581.
Fried LP, Young Y, Rubin G, Bandeen-Roche K, and for the WHAS II Collaborative Research Group. (2001) Self-reported preclinical disability identifies older women with early declines in performance and early disease. J Clinc Epi 54(9), 889–901.
Garrett CE and Fried LP. (2000) Screening for risk of mobility disability in the clinical setting. Arch Intern Med 160, 2525–2533.
Fried LP, Bandeen-Roche K, Chaves PH, Johnson BA. (2000) Preclinical mobility disability predicts incident mobility disability in older women. J Gerontol A Biol Sci Med Sci Jan: 55(1):M43–M52.
Romero-Ortuno R, Walsh CD, Lawlor BA, Kenny RA. (2010) A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatrics, 2010, 10:57. http://www.biomedcentral.com/1471-2318/10/57.
Despite Risks, Americans Are Not Taking Action to Protect Themselves Against Muscle Loss as They Age. June 09, 2010 http://www.abbott.com/global/url/pressRelease/en_US/Press_Release_0872.
Weiss CO, Hoenig HM, Fried LP. (2007) Compensatory strategies used by older adults facing mobility disability. Arch Phys Med Rehab Sept; 88;1217–1220
Evans CJ, Chiou CF, Fitzgerald KA, Evans WJ, Ferrell BR, Dale W, Fried LP, Gandra SR, Dennee-Sommers B, Patrick DL. (2011) Development of a new patientreported outcome measure in sarcopenia. J Am Med Dir Assoc Mar; 12(3);226–233.
Pel-Littel RE, Schuurmans MJ, Emmelot-Vonk M, Verhaar HJ. (2009) Frailty: defining and measuring of a concept. J Nutr Health Aging Apr; 13(4):390–394.
Gobbens RJJ, Luijkx KG, Wijnen-Sponselee MT, Schols JMGA. (2010) Towards an integral conceptual model of frailty. J Nutr Health Aging Mar; 14(3):175–181
Doruk H, Naharci, MI, Bozoglu E, Isik, AT. Kilic S. (2010) The relationship between body mass index and incidental mild cognitive impairment, Alzheimer’s disease, and Vascular Dementia in elderly. J Nutr Health Aging Dec; 14(10):834–838.
Abellan van Kan G, André E, Bischoff-Ferrari HA, Boirie Y, Onder G, Pahor M, Ritz P, Rolland Y, Sampaio C, Studenski S, Visser M, Vellas B. (2009) Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging Oct; 13(8):700–707.
Studenski S, Hayes RP, Leibowitz RQ, Bode R, Lavery L, Walston J, Duncan P, Perera S. (2004) Clinical global impression of change in physical frailty: development of a measure based on clinical judgement. J Am Geriatr Soc 52:1560–1566.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Waters, D.L. Pro-dromal sarcopenia. J Nutr Health Aging 15, 832–833 (2011). https://doi.org/10.1007/s12603-011-0364-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-011-0364-2